CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- 10-K Report Annual Report
- UPLOAD Other SEC-generated Letter
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Auditor change
- 8-K/A Event Auditor change
- 8-K Event Auditor change
- SC 13D Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
Page 25 of 36 · 707 filings